Brief: 60 Degrees Pharmaceuticals Awarded Canadian Patent Covering Tafenoquine
31/07/2023 14:19
July 31 (Reuters) - 60 Degrees Pharmaceuticals Inc
SXTP.O :
* 60 DEGREES PHARMACEUTICALS AWARDED CANADIAN PATENT
COVERING
TAFENOQUINE FOR PREVENTION OF MALARIA IN MALARIA-NAIVE SUBJECTS
* 60 DEGREES-CANADIAN PATENT PROVIDES EXCLUSIVE USE OF
TAFENOQUINE
FOR PREVENTING MALARIA IN MALARIA-NAIVE PATIENTS IN CANADA TO
DEC 2, 2035
Source text for Eikon: ID:nGNX9WRWv3
Further company coverage: SXTP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 60 Degrees Pharmaceuticals
See all newsBrief: 60 Degrees Pharmaceuticals Says May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028 - SEC Filing
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM